Prosecution Insights
Last updated: April 19, 2026

Examiner: PHAM, KHAI QUYNH TIEN

Tech Center 1600 • Art Units: 1684

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
12
Total Applications
+0.0%
Interview Lift
1175
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

8.7%
§101 Eligibility
19.6%
§102 Novelty
43.5%
§103 Obviousness
26.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18213088 METHODS, COMPOSITIONS, AND SYSTEMS FOR DETECTING EXOGENOUS NUCLEIC ACIDS Non-Final OA 10x Genomics, Inc.
18054503 PARALLEL SINGLE-CELL REPORTER ASSAYS AND COMPOSITIONS Non-Final OA Washington University
18335963 METHODS AND COMPOSITIONS FOR PROTEIN FINGERPRINTING Non-Final OA Quantum-Si Incorporated
18268470 METHOD FOR SCREENING FOR CANDIDATE MOLECULE CAPABLE OF FORMING COMPLEX IN CONJUNCTION WITH PLURALITY OF TARGET MOLECULES Non-Final OA Chugai Seiyaku Kabushiki Kaisha
18244592 ENRICHMENT OF GENETIC MATERIAL WITH UPSCALED COT-1 DNA QUANTITIES Non-Final OA Helix, Inc.
17980755 SYSTEMS AND METHODS FOR PREPARING BIOLOGICAL SAMPLES FOR GENETIC SEQUENCING Final Rejection Universal Diagnostics, S.A.
18276116 SYSTEMS AND METHODS FOR EVALUATING DRUG COMBINATIONS Non-Final OA Hunter BioDiscovery, Inc.
18168528 COMBINATORIAL DNA ASSEMBLY FOR MULTISPECIFIC ANTIBODIES Non-Final OA TWIST BIOSCIENCE CORPORATION
18034732 TARGETED SEQUENCING METHOD AND KIT THEREOF FOR DETECTING GENE ALTERATION Non-Final OA ACT GENOMICS (IP) CO., LIMITED

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month